Stocktoria
Elevance Health, Inc. ELV
NYSE · XNYS · stock · Hospital & Medical Service Plans · website · IPO 2001-10-30
Elevance Health, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $199.1B | $177.0B | $171.3B | $156.6B | $138.6B |
| SG&A expense | $21.0B | $20.0B | $20.1B | $17.7B | $15.9B |
| Operating income | $7.2B | $7.9B | $8.5B | $8.3B | $7.6B |
| Interest expense | — | — | $1.0B | $851.0M | $798.0M |
| Income tax | $1.0B | $1.9B | $1.7B | $1.7B | $1.8B |
| Net income | $5.7B | $6.0B | $6.0B | $5.9B | $6.2B |
| EPS (diluted) | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 |
| Operating cash flow | $4.3B | $5.8B | $8.1B | $8.4B | $8.4B |
| Free cash flow | $3.2B | $4.6B | $6.8B | $7.2B | $7.3B |
| Cash & equivalents | $9.5B | $8.3B | $6.5B | $7.4B | $4.9B |
| Total assets | $121.5B | $116.9B | $108.9B | $102.8B | $97.5B |
| Total liabilities | $77.5B | $75.5B | $69.5B | $66.4B | $61.3B |
| Shareholders' equity | $44.0B | $41.4B | $39.4B | $36.3B | $36.1B |
Source: SEC EDGAR filings · CIK 0001156039 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.